LFVN LIFEVANTAGE CORP
FollowCOMMON STOCK (common), issuer CIK 849146
Filings received so far for Q3 2026: 1 13F filer report a position in LFVN shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Cunningham Kristenofficer (Chief Sales Officer) | 2026-10-07 | +32,850 A | $0 | Form 4 |
| Aure Carlofficer (Chief Financial Officer) | 2026-10-07 | +35,749 A | $0 | Form 4 |
| Moorehead Terrencedirector, officer (President and CEO) | 2026-10-07 | +193,237 A | $0 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GAMMA Investing LLC | 1,440 | $9.07K | <0.01% | -38 | 13F-HRTimeline |
Events
Cunningham Kristen acquired 32,850 LFVN shares on 2026-10-07, Form 4 filed 2026-10-09. 0001193125-26-419109
Accepted , ingestedAure Carl acquired 35,749 LFVN shares on 2026-10-07, Form 4 filed 2026-10-09. 0001193125-26-419094
Accepted , ingestedMoorehead Terrence acquired 193,237 LFVN shares on 2026-10-07, Form 4 filed 2026-10-09. 0001193125-26-419076
Accepted , ingested